Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Does CG0070 have better efficacy than Ruvidar PDT?

<< Previous

Bullboard Posts

Next >>

Comment by greaterfoolFredon Jan 29, 2024 1:48pm

306 Views

Post# 35850891

RE:RE:RE:RE:RE:RE:Does CG0070 have better efficacy than Ruvidar PDT?

It doesn't matter if we have the very best efficacy. We have good efficacy. But we will be the logical first choice because our treatment is safe, simple, and probably the cheapest. If it fails the patient will know quickly, and can then move on to one of the nastier treatments.

<< Previous

Bullboard Posts

Next >>

Dollar Tree CEO Rick Dreiling steps down as discount retailer struggles